1. Home
  2. MXC vs NEUP Comparison

MXC vs NEUP Comparison

Compare MXC & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MXC

Mexco Energy Corporation

HOLD

Current Price

$8.76

Market Cap

20.8M

Sector

Energy

ML Signal

HOLD

NEUP

Neuphoria Therapeutics Inc.

HOLD

Current Price

$5.08

Market Cap

23.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXC
NEUP
Founded
1972
1996
Country
United States
United States
Employees
N/A
8
Industry
Oil & Gas Production
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
20.8M
23.8M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
MXC
NEUP
Price
$8.76
$5.08
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$21.00
AVG Volume (30 Days)
8.8K
34.7K
Earning Date
02-10-2026
05-23-2026
Dividend Yield
1.02%
N/A
EPS Growth
30.65
N/A
EPS
0.30
N/A
Revenue
$2,705,235.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$29.20
N/A
Revenue Growth
7.12
N/A
52 Week Low
$6.75
$3.65
52 Week High
$16.48
$21.31

Technical Indicators

Market Signals
Indicator
MXC
NEUP
Relative Strength Index (RSI) 39.26 53.76
Support Level $8.57 $3.91
Resistance Level $9.65 $5.45
Average True Range (ATR) 0.49 0.26
MACD -0.04 -0.05
Stochastic Oscillator 0.57 63.46

Price Performance

Historical Comparison
MXC
NEUP

About MXC Mexco Energy Corporation

Mexco Energy Corporation is an independent oil and gas company. It is engaged in the acquisition, exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.

About NEUP Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

Share on Social Networks: